Ageless Future
Exploring the Next Generation of Metabolic Health Innovations
20:59
In this episode of the Ageless Future Podcast, Cade Archibald explores emerging developments in metabolic health, comparing two investigational therapies—an oral GLP-1 medication (orforglipron) and the injectable triple-agonist retatrutide. The discussion highlights how these therapies differ in delivery methods, mechanisms of action, and areas of ongoing clinical research, while emphasizing…